ALBERTDAVD850.00

Albert David Limited

· Pharma & Health
₹ CrorePeersVALIANTLABHALEOSLABSZIMLABMEDICOMEDICAMEQANUHPHRAHCLWANBURYMcap ₹485 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity19.694.38-0.38-0.38
Return on Assets15.143.36-0.29-0.29
Return on Capital Employed10.04-0.97-1.06-1.06
Return on Invested Capital24.77-1.68-0.887.11
Margins
EBITDA Margin12.930.881.647.34
Operating Margin11.05-1.14-1.29-1.29
Incremental Operating Margin263.552.91
Pretax Margin26.847.300.167.65
Net Income Margin20.814.97-0.456.19
FCF Margin9.55-12.52-2.30-2.30
Additional
Effective Tax Rate22.4831.82384.7619.06
Dvd Payout Ratio6.851.44-191.60
Sustainable Growth Rate18.344.32-1.11-0.38
Incremental Operating Margin %263.552.9169.52
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.